Abstract:Objective To investigate the value of clinical application of fluorine-18-deoxyglucose(18F-FDG) positron emission tomography(PET-CT) and CT enhanced scan in the diagnosis of primary lesion of hypopharyngeal lesions, cervical lymph node metastasis and distant metastasis.Methods Forty-four clinical cases of hypopharyngeal carcinoma were collected from October 2011 to August 2012 in the First Affiliated Hospital of Anhui Medical University of The sensitivity, specificity, accuracy, positive and negative predictive values of PET-CT and CT enhanced scan, and their advantages and disadvantages in the diagnose of hypopharyngeal carcinoma were compared.Results PET-CT was better than CT enhanced scan in the diagnosis of hypopharyngeal primary tumors, lymph node metastasis, distant metastasis in the sensitivity, specificity, accuracy, positive predictive value and negative predictive values. The sensitivity, specificity and accuracy of CT enhanced scan in diagnosing primary tumor of hypopharyngeal carcinoma were 97.44%(38/29), 3/5 and 93.18%(41/44), respectively. The sensitivity, specificity and accuracy of 18F-FDG PET/CT in diagnosing primary tumor of hypopharyngeal carcinoma were 100.00%(20/20), 1/1 and 100.00%(21/21). The sensitivity, specificity and accuracy of CT Enhanced Scan in diagnosing neck lymph node metastasis of hypopharyngeal carcinoma were 73.91%(17/23), 52.38%(11/21) and 63.64%(28/44), respectively. The sensitivity, specificity and accuracy of 18F-FDG PET/CT in diagnosing neck lymph node metastasis of hypopharyngeal carcinoma were 16/16, 4/5 and 95.24%(20/21) respectively, with statistically significant difference(all P values<0.05). The sensitivity, specificity and accuracy of CT enhanced scan in diagnosing distant metastasis of hypopharyngeal carcinoma were 2/4, 97.50%(39/40) and 93.18%(41/44), respectively. The sensitivity, specificity and accuracy of 18F-FDG PET/CT in diagnosing distant metastasis of hypopharyngeal carcinoma were 5/5, 16/16 and 100.00%(21/21), respectively, with no statistically significant difference(all P values>0.05).Conclusions PET/CT is superior to simple neck and chest enhancement CT in the diagnosis of primary lesion of hypopharyngeal carcinoma, cervical lymph node metastasis and distant metastasis. There are no statistical differences in the advantages for primary lesion and distant metastasis. However, PET/CT shows higher diagnostic capability and statistically significant superiority in the sensitivity, accuracy, positive and negative predictive values of cervical lymph node metastasis.
秦茂林,刘业海,姚长玉,吴开乐,高潮兵,童步升,赵益,吴静,李亦凡. 正电子发射计算机体层成像-CT与CT增强扫描在下咽癌诊治中的应用价值[J]. 中华解剖与临床杂志, 2016, 21(1): 6-11.
Qin Maolin, Liu Yehai, Yao Changyu, Wu Kaile, Gao Chaobing, Tong Busheng, Zhao Yi, Wu Jing, Li Yifan. The application value of positron emission tomography-CT and CT enhanced scan in the diagnosis and treatment of hypopharyngeal carcinoma. Chinese Journal of Anatomy and Clinics, 2016, 21(1): 6-11.
Rodrigues RS, Bozza FA, Christian PE, et al. Comparison of whole-body PET/CT, dedicated high-resolution head and neck PET/CT, and contrast-enhanced CT in preoperative staging of clinically M0 squamous cell carcinoma of the head and neck[J]. J Nucl Med, 2009, 50(8): 1205-1213. DOI:10.2967/jnumed.109.062075
Tantiwongkosi B, Yu F, Kanard A, et al. Role of 18F-FDG PET/CT in pre and post treatment evaluation in head and neck carcinoma[J]. World J Radiol, 2014, 6(5): 177-191. DOI:10.4329/wjr.v6.i5.177
[8]
Kim SY, Kim JS, Doo H, et al. Combined [18F] fluorodeoxyglucose positron emission tomography and computed tomography for detecting contralateral neck metastases in patients with head and neck squamous cell carcinoma[J]. Oral Oncol, 2011, 47(5): 376-380. DOI:10.1016/j.oraloncology.2011.03.018
[9]
陆海杰, Ribere-Brugel L, Itti E, et al. PET/CT与增强CT诊断头颈肿瘤颈淋巴结转移的对比研究[J]. 现代肿瘤医学, 2007, 15(11): 1555-1557. DOI:10.3969/j.issn.1672-4992.2007.11.008
[10]
Schder H, Carlson DL, Kraus DH, et al. 18F-FDG PET/CT for detecting nodal metastases in patients with oral cancer staged N0 by clinical examination and CT/MRI[J]. J Nucl Med, 2006, 47(5): 755-762
[11]
Fukui MB, Blodgett TM, Snyderman CH, et al. Combined PET-CT in the head and neck: part 2. Diagnostic uses and pitfalls of oncologic imaging[J]. Radiographics, 2005, 25(4): 913-930. DOI:10.1148/rg.254045136
[12]
Wong R, Lin D, Schder H. Diagnostic and prognostic value of[(18)F]fluorodeoxyglucose positron emission tomography for recurrent head and neck squamous cell carcinoma[J]. J of Clin Oncol[J], 2002, 20(20): 4199-4208
[13]
Ng SH, Yen TC, Liao CT, et al. 18F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation[J]. J Nucl Med, 2005, 46(7): 1136-1143
[14]
Haerle SK, Schmid DT, Ahmad N, et al. The value of 18F-FDG PET/CT for the detection of distant metastases in high-risk patients with head and neck squamous cell carcinoma[J]. Oral Oncol, 2011, 47(7): 653-659. DOI:10.1016/j.oraloncology.2011.05.011
[15]
de la Torre S, Moragas M, Durany D, et al. Diagnostic sequence of MRI and PET/CT in a case of bone metastases by hypopharyngeal squamous cell carcinoma[J]. Rev Esp Med Nucl Imagen Mol, 2012, 31(2): 101-102. DOI:10.1016/j.remn.2011.04.003
[16]
Schder H, Yeung HW, Gonen M, et al. Head and neck cancer: clinical usefulness and accuracy of PET/CT image fusion[J]. Radiology, 2004, 231(1): 65-72. DOI:10.1148/radiol.2311030271
[17]
Kim JW, Roh JL, Kim JS, et al. Evaluation of 18F-FDG PET/CT and CT/MRI with histopathologic correlation in patients undergoing central compartment neck dissection for squamous cell carcinoma of the larynx, hypopharynx, and esophagus[J]. Oral Oncol, 2013, 49(5): 449-453. DOI:10.1016/j.oraloncology.2012.12.007
[18]
Kanda T, Kitajima K, Suenaga Y, et al. Value of retrospective image fusion of 18F-FDG PET and MRI for preoperative staging of head and neck cancer: comparison with PET/CT and contrast-enhanced neck MRI[J]. Eur J Radiol, 2013, 82(11): 2005-2010. DOI:10.1016/j.ejrad.2013.06.025.